Lipocine Announces Continued Commercialization of TLANDO® through Verity Pharmaceuticals
SALT LAKE CITY, Feb. 2, 2024 /PRNewswire/ -- Lipocine Inc. , a biopharmaceutical company focused on treating Central Nervous System disorders, today announced that commercialization of TLANDO® in...
Source: marketscreener.com